Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers

Aiming towards the development of novel nootropic therapeutics to address the cognitive impairment common to a range of brain disorders, we set out to develop highly selective small molecule inhibitors of HDAC2, a chromatin modifying histone deacetylase implicated in memory formation and synaptic pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, F. F., Zhang, Y.-L., Fass, D. M., Joseph, N., Gale, J. P., Weïwer, M., McCarren, P., Fisher, S. L., Kaya, T., Zhao, W.-N., Reis, S. A., Hennig, K. M., Thomas, M., Lemercier, B. C., Lewis, M. C., Guan, J. S., Moyer, M. P., Scolnick, E., Haggarty, S. J., Tsai, L.-H., Holson, E. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2015
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310013/
https://www.ncbi.nlm.nih.gov/pubmed/25642316
http://dx.doi.org/10.1039/c4sc02130d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310013/
https://www.ncbi.nlm.nih.gov/pubmed/25642316
http://dx.doi.org/10.1039/c4sc02130d

Ejemplares similares